Vol. 20 No. 1 (2016)
CASE REPORTS

Clinical morphological analysis of Contegra dysfunction in infants

I. Zhuravleva
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, 15 Rechkunovskaya St., 630055 Novosibirsk
N. Nichai
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, 15 Rechkunovskaya St., 630055 Novosibirsk
A. Dokuchaeva
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, 15 Rechkunovskaya St., 630055 Novosibirsk
I. Soinov
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, 15 Rechkunovskaya St., 630055 Novosibirsk
S. Ivantsov
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, 15 Rechkunovskaya St., 630055 Novosibirsk
I. Keil
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, 15 Rechkunovskaya St., 630055 Novosibirsk
A. Omelchenko
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, 15 Rechkunovskaya St., 630055 Novosibirsk
Yu. Gorbatykh
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, 15 Rechkunovskaya St., 630055 Novosibirsk
A. Gorbatykh
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, 15 Rechkunovskaya St., 630055 Novosibirsk

Published 2016-03-25

Keywords

  • reconstruction,
  • right ventricle outflow,
  • conduit dysfunction,
  • pseudointimal hyperplasia

How to Cite

Zhuravleva, I., Nichai, N., Dokuchaeva, A., Soinov, I., Ivantsov, S., Keil, I., Omelchenko, A., Gorbatykh, Y., & Gorbatykh, A. (2016). Clinical morphological analysis of Contegra dysfunction in infants. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 20(1), 56–61. https://doi.org/10.21688/1681-3472-2016-1-56-61

Abstract

The Contegra valve-containing conduit (Medtronic) has been used for reconstruction of right ventricle outflow pathway in congenital heart disease surgery since 1999. The literature on immune inflammation of a xenovein is scarce and controversial. We present a clinical case of a pronounced cellular immune response to the Contegra device.

References

  1. Holmes AA, Co S, Human DG, LeBlanc JG, Campbell AIM. The Contegra conduit: Late outcomes in right ventricular outflow tract reconstruction. Ann Pediatr Cardiol. 2012;5(1):27-33. doi: 10.4103/0974-2069.93706.
  2. Shi-Min Yuan. The Contegra Valved Bovine Conduit: A Biomaterial for the Surgical Treatment of Congenital Heart Defects. Arq Bras Cardiol. 2012;99(6):1159-65.
  3. Yong MS, Yim D, d’Udekem Y, Brizard CP, Robertson T, Galati JC, Konstantinov IE. Medium-term outcomes of bovine jugular vein graft and homograft conduits in children. ANZ J Surg. 2015;85(5):381-5. doi: 10.1111/ans.13018.
  4. Urso S, Rega F, Meuris B, Gewillig M, Eyskens B, Daenen W, Heying R, Meyns B. The Contegra conduit in the right ventricular outflow tract is an independent risk factor for graft replacement. Eur J Cardio-thorac Surg. 2011;40(3):603-9. doi: 10.1016/j.ejcts.2010.11.081.
  5. Lukyanov AA, Karaskov AM, Gorbatykh YuN, Naberukhin YuL, Omelchenko AYu, Gorbatykh AV, Sergeevichev DS, Khapaev TS. Immediate postoperative results and long term outcome after Ross procedure among the pediatric population. Patologiya krovoobrashcheniya i kardiokhirurgiya [Circulation Pathology and Cardiac Surgery]. 2014;2:5-9.
  6. Meyns B, Van Garsse L, Boshoff D, Eyskens B, Mertens L, Gewillig M, Fieuwsc S, Verbeken E, Daenen W. The Contegra conduit in the right ventricular outflow tract induces supravalvular stenosis. J Thorac Cardiovasc Surg. 2004;128(6):834-40.
  7. Mery CM, Guzman-Prune FA, DeLeon LE, Zhang W, Terwelp MD, Bocchini CE, Adachi I, Heinle JS, McKenzie D, Fraser CD Jr. Risk factors for development of endocarditis and reintervention in patients undergoing right ventricle to pulmonary artery valved conduit placement. J Thorac Cardiovasc Surg. 2004;151(2):432-41.e2.
  8. Göber V, Berdat P, Pavlovic M, Pfammatter J-P, Carrel TP. Adverse Mid-Term Outcome Following RVOT Reconstruction Using the Contegra Valved Bovine Jugular Vein. Ann Thorac Surg. 2005;79(2):625-31.
  9. Wojtalik M, Mrowczynski W, Zeromski J, Bartkowski R. Does contegra xenograft implantation evoke cellular immunity in children? Interact Cardiovasc Thorac Surg. 2003;2(3):273-8.
  10. Schoenhoff FS, Loup O, Gahl B, Banz Y, Pavlovic M, Pfammatter J-P, Carrel TP, Kadner A. The Contegra bovine jugular vein graft versus the Shelhigh pulmonic porcine graft for reconstruction of the right ventricular outflow tract: A comparative study. J Thorac Cardiovasc Surg. 2011;141(3):654-61. doi: 10.1016/j.jtcvs.2010.06.068.
  11. Boudjemline Y, Beyler C, Bonnet D, Sidi D. Surprising outcome similarities between Contegra bovine jugular vein conduit and Shelhigh No-React porcine pulmonary valve condit: role of immunological reaction. Eur J Cardiothorac Surg. 2003;24:850-1. doi:10.1016/S1010-7940(03)00509-8.